Stock·NYSE·Consumer Defensive
Philip Morris International Inc (PM)
- Market cap
- $319.83B
- P/E
- 28.63
- Dividend yield
- 2.93%
- Street target
- $211.00median of 16 analysts
- 52-week range
- $142.11 $210.45
The short version
Where PM stands today, in four lines, and what CleaRank Financial AI makes of it.
PM at a glance
Philip Morris International Inc (PM): Buy, 78/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($191.28 and $179.83).
- Insiders Insiders sold $28.8M and made no open-market purchases over the last 18 months.
- Valuation P/E of 28.6 against 24.2 for the Consumer Defensive sector: broadly in line with peers (+18%).
Figures as of October 17, 2026.
CleaRank Financial AI
Philip Morris International Inc (PM) receives a Buy rating from CleaRank, with a model score of 78/100.
Trend is the strongest contributor: the price is 13.98% above its 200-day average and 7.16% above its 50-day average, and the 50-day average is 6.36% above the 200-day. Valuation is the largest drag, with the P/S of 7.53 242.3% above the sector median. The 50-day average is $191.28 and the 200-day is $179.83. The price has climbed 31.41% over the last twelve months.
Only on CleaRank
Figures we compute ourselves from PM's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $204.97 is 7.2% above the 50-day simple moving average of $191.28.Price above its 200-day average ›
The price is 14.0% above the 200-day simple moving average of $179.83.50-day average above the 200-day ›
The 50-day average ($191.28) is 6.4% above the 200-day average ($179.83), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 92% of its 52-week range, between $142.11 and $210.45.
PM share price
Pick a period: each tab shows how far PM has moved over it, to the last close.
Today's trading
Where PM sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 28.63 is 18.3% above the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 7.53 is 242.3% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $10.8B on revenue of $42.5B, a net margin of 25.5%.Pays a dividend ›
The trailing dividend yield is 2.93%, or $6.01 a share a year.
Key statistics
The headline figures for PM.
As of October 17, 2026, PM trades at $204.97, with a market value of $319.83B, a P/E ratio of 28.63 and a dividend yield of 2.93%.
What the numbers say
CleaRank Financial AI's reading of PM's valuation, growth and risks.
Against the 24.2 median P/E of Consumer Defensive stocks, PM's P/E of 28.63 is 18.3% above that median, which counts as broadly in line with peers. Measured against sales, the P/S of 7.53 is 242.3% above the sector median of 2.2. For scale, PM carries a market value of $319.8B and trailing earnings of $7.18 a share.
Revenue grew 10.40% over the latest year, which is 5.1 percentage points ahead of the 5.3% median for Consumer Defensive. PM turns sales into profit at a net margin of 25.56% and an operating margin of 40.00%, alongside a return on equity of -140.96%, below the sector median of 19.7%. It also reports a trailing dividend yield of 2.93% ($6.01 a share a year).
In its most recent available report in our data, on July 22, 2025, PM posted EPS of $1.91 versus the $1.86 analysts expected, coming in above the estimate by 2.69%. Even so, the share price fell 0.36% in the first session after the report.
The record is a clean sweep: 2 beats in 2 reports; even so, 1 of those 2 beats was followed by a lower share price the next session. Looking ahead, analysts expect EPS of $8.41 this fiscal year (growth of 11.6%) and $9.19 the year after (growth of 9.2%).
On a typical day the price of PM shifts by 1.50%, the 30-day standard deviation of its daily returns. Over the last 18 months, insider sales totalled $28.8M with no open-market purchases; planned sales and tax sales on vesting shares make selling a weaker signal than buying.
PM against the Consumer Defensive sector
How PM compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (18% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 6, 2025, PM has gained 17.7% against a gain of 36.6% for SPY.
Performance against SPY
PM and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much PM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 7.3% in FY2025 to $40.6B, from $37.9B a year earlier.
Profit margin: The net margin was 29.1% in FY2025, up from 19.8% the year before.
Profitable: PM earned $11.8B in FY2025.
Earnings reality check
Did PM beat what analysts expected, and how did the stock react?
Earnings record: PM beat the analyst estimate in 2 of the last 2 quarters.
Market reaction: The stock fell in the first session after 1 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 22, 2025after close | $1.86 | $1.91 | +2.69% | -0.36% | -1.52% |
| Apr 23, 2025after close | $1.61 | $1.69 | +4.97% | +1.17% | +1.93% |
The August 25, 2026 report is not shown: the figures our data provider supplied for it failed our checks.
As of October 17, 2026, PM has beaten the analyst EPS estimate in 2 of its last 2 reported quarters and fell in the first trading session after 1 of those beats; its most recent report with reliable figures, on July 22, 2025, came in 2.69% above the estimate and the stock moved -0.36% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 63.6, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 63.6 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of PM
The score, the reasoning behind it, and what could move the price next.
Philip Morris International Inc (PM) trades at $204.97, above both of its main moving averages. The price sits 7.16% above its 50-day average of $191.28 and 13.98% above its 200-day average of $179.83. That places it at 92% of its 52-week range, and it is 2.60% below the 52-week high of $210.45. Because the 50-day average is 6.36% above the 200-day average, the shorter-term trend is pulling ahead of the longer one.
On momentum, the 14-day RSI reads 63.6, in the bullish zone, below the overbought line, with the MACD line positive. Every period on the chart shows a gain, with the price up 6.21% over the past three months, 29.90% over the past six months and 31.41% over the past year. The price rose 2.54% in the last session on volume 50.5% above its average.
Earnings beat ›
The July 22, 2025 report beat the EPS estimate by 2.69%, and the share price fell 0.36% in the first session after it.
Source: Earnings report, July 22, 2025
Rating reaffirmed ›
UBS kept its Neutral rating on September 23, 2026.
Source: Analyst action, UBS, September 23, 2026
- Keep an eye on the two closest levels: the 52-week high at $210.45 overhead and the 20-day EMA at $196.27 underneath the price.
- A 14-day RSI of 63.6 sits in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum in either direction.
- The share price dropped 0.36% in the first session after the July 22, 2025 report, even though PM had beaten estimates in 2 of its last 2 reports.
PM trades above its 50-day and 200-day moving averages ($191.28 and $179.83), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 20-day EMA at $196.27.
PM's next level overhead is the 52-week high at $210.45. The RSI is in the bullish band, which backs the current direction without signalling an overstretched move.
Technical indicators
Momentum and trend for PM, from its daily closes.
As of October 17, 2026, with PM at $204.97, its 14-day RSI is 63.6 (showing bullish momentum without being overbought), its 50-day simple moving average is $191.28 and its 200-day is $179.83.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What PM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, PM's 1-year correlation of daily returns is +0.01 with S&P 500 (SPY), -0.09 with Nasdaq 100 (QQQ), -0.03 with Bitcoin (BTC) and +0.05 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
12 of 16 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $211.00 is 2.9% above the price.More buy ratings than three months ago ›
12 of 16 rate it a buy now, against 11 of 16 three months ago.
PM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 23, 2026 | UBS | Maintains | Neutral |
| Jul 30, 2026 | Citigroup | Maintains | Buy |
| Jul 29, 2026 | Barclays | Maintains | Overweight |
| Jul 23, 2026 | Morgan Stanley | Maintains | Overweight |
| Jul 23, 2026 | Stifel | Maintains | Buy |
| Jul 23, 2026 | Needham | Maintains | Buy |
As of October 17, 2026, 16 Wall Street analysts cover PM: 12 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $175.00 to $230.00, with a median of $211.00, 2.9% above the price of $204.97.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from PM's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PM tends to move, against the market and on its own.
The long record
PM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.50% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 41.5%, from June 2017 to December 2018, regained by June 2021.Most 1-year holds ended higher ›
73% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $34,867, against $42,058 in the S&P 500 (SPY).
PM Drawdowns & Recovery
As of October 17, 2026, PM's worst peak-to-trough fall over the last 10 years with dividends reinvested was -41.5% (June 2017 to December 2018); it regained that peak by June 2021, 30 months after the low, and 73% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PM in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: PM trailed the S&P 500 over this period: $34,867 against $42,058.
A $10,000 investment in PM in October 2016 would be worth about $34,867 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PM, and which have not.
Strongest month, February: an average of +4.98%, up in 5 of 10 years.
Weakest month, March: an average of -3.52%, up in 4 of 10 years.
This month, October: has averaged +0.74%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, PM's strongest calendar month has been February (average +4.98%, up in 5 of 10 years) and its weakest March (average -3.52%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PM today could grow to about $19,627 by 2036 in the base case, with a 90th-percentile outcome near $54,573 and a 10th-percentile outcome around $7,059. The simulation models price only; at today's 2.93% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
PM Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $268 for PM by 2030 in the base case, from $205 today (1.3x over 4 years). The 10th-percentile path ends near $141. These are outcomes of a Monte Carlo simulation run on PM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $159 | $219 | $303 | |
| 2028 | $148 | $235 | $371 | |
| 2029 | $143 | $251 | $439 | |
| 2030 | $141 | $268 | $513 | |
| 2031 | $139 | $287 | $592 |
Method: a lognormal simulation of PM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
PM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought PM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, PM insiders reported 6 open-market sales worth $28.8M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 6, 2026 | Bonin Bough
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Andre Calantzopoulos
Chairman of the Board
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Michel Combes
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Werner Geissler
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Victoria D Harker
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Lisa A. Hook
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Kalpana Morparia
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Robert Polet
Director
|
Grant | 1.1K | $190.2K |
| May 6, 2026 | Shlomo Yanai
Director
|
Grant | 1.1K | $190.2K |
| Feb 20, 2026 | Stacey Kennedy
Officer
|
Sell | 14.4K | $2.6M |
| Feb 20, 2026 | Reginaldo Dobrowolski
Officer
|
Sell | 6.0K | $1.1M |
| Feb 19, 2026 | Jacek Olczak
Officer and Director
|
Sell | 80.0K | $14.6M |
| Feb 19, 2026 | Emmanuel Babeau
Officer
|
Sell | 33.8K | $6.1M |
| Feb 19, 2026 | Wilde Frederic J De
Officer
|
Sell | 20.0K | $3.7M |
| Feb 19, 2026 | Yann Guerin
Officer
|
Sell | 4.0K | $726.8K |
| Feb 6, 2026 | Emmanuel Babeau
Officer
|
Grant | 61.4K | $2.0M |
| Feb 6, 2026 | Wilde Frederic J De
Officer
|
Grant | 33.1K | $1.8M |
| Feb 6, 2026 | Reginaldo Dobrowolski
Officer
|
Grant | 6.5K | $466.9K |
| Feb 6, 2026 | Yann Guerin
Officer
|
Grant | 8.3K | $873.3K |
| Feb 6, 2026 | Stacey Kennedy
Officer
|
Grant | 16.2K | $766.1K |
| Feb 6, 2026 | Jacek Olczak
Officer and Director
|
Grant | 171.0K | $5.8M |
| Feb 5, 2026 | Andre Calantzopoulos
Chairman of the Board
|
Grant | 40.1K | - |
| May 7, 2025 | Bonin Bough
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Andre Calantzopoulos
Chairman of the Board
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Michel Combes
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Werner Geissler
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Victoria D Harker
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Lisa A. Hook
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Kalpana Morparia
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Robert Polet
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Dessislava Temperley
Director
|
Grant | 1.0K | $175.2K |
| May 7, 2025 | Shlomo Yanai
Director
|
Grant | 1.0K | $175.2K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.